Epalrestat - Drug Information

Generic Name : Epalrestat
Pronunciation : Ep-al-re-stat

ICD Code : | Therapeutic Classification : Antidiabetics

Trade Name(s) :

India - Aldorace (50mg), Restat (50mg), Alrista (50mg), Alrista (150mg)


International - Aldorace, Aldonil, Alrista, Eparel, Aldorace, Epo, Epalridase, Aristat, Epalpex, Restat

Overview of Epalrestat

� Epalrestat is used for the treatment of nerve damage in diabetes patients.

Why is Epalrestat Prescribed? (Indications)

Epalrestat is used for the treatment of nerve damage due to diabetes called diabetes neuropathy.
It inhibits the enzyme aldose reductase and reduces the level of sorbitol, which damages the nerves.

When should Epalrestat not to be taken? (Contraindications)

� Epalrestat is contraindicated in patient with allergies and severe liver disease.

What is the dosage of Epalrestat?

� The recommended dose of epalrestat is 50 mg tablet taken orally three times a day before meals.

How should Epalrestat be taken?

� Epalrestat should be ideally taken before meals.

What are the warnings and precautions for Epalrestat?

� Caution is advised in cases of kidney impairment.

What are the side effects of Epalrestat?

Gastrointestinal disorder: Nausea, vomiting, diarrhea
Skin: Redness, rash, and skin blistering
Liver: Increase in liver enzymes
Kidney: Kidney dysfunction, edema
Nervous system: Dizziness, drowsiness, headache
Others: High blood pressure

What are the other precautions for Epalrestat?

� Do not take if you are pregnant, breastfeeding or planning to become pregnant unless you consult your doctor.
� Do not use heavy machinery or drive while taking the drug due to possible dizziness and drowsiness.

What are the Drug Interactions of Epalrestat?

Not known

What are the storage conditions for Epalrestat?

It should be stored at room temperature unless otherwise specified.